Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PLX | BMY | AMGN | GILD | REGN |
| Company | Protalix Biotherapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0700 | 76.25 | 246.62 | 62.62 | 594.79 |
| High | 1.1000 | 77.10 | 248.08 | 62.88 | 601.88 |
| Low | 1.0700 | 75.97 | 244.54 | 62.16 | 588.91 |
| Last | 1.0900 | 76.22 | 245.25 | 62.73 | 594.90 |
| Change | unch | +0.26 | -1.48 | +0.39 | -1.66 |
| % Change | unch | +0.34% | -0.60% | +0.63% | -0.28% |
| Volume | 112,000 | 8,618,600 | 4,320,600 | 5,888,100 | 528,800 |
| 20-Day Average Volume | 146,290 | 13,045,390 | 3,731,715 | 7,630,455 | 739,620 |
| Previous Close | 1.0900 | 75.96 | 246.73 | 62.34 | 596.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0953 | 76.12 | 241.44 | 61.14 | 586.62 |
| 20-Day Raw Stochastic | 35.74% | 50.79% | 84.78% | 87.43% | 67.06% |
| 20-Day Relative Strength | 47.78% | 50.54% | 52.38% | 53.47% | 44.31% |
| Weighted Alpha | -45.07 | +18.40 | +4.46 | -8.50 | -2.92 |
| Today's Opinion | 40% Buy | 88% Buy | 72% Buy | 32% Sell | 72% Sell |
| Previous Opinion | 40% Buy | 56% Buy | 72% Buy | 32% Sell | 72% Sell |
| Last Month's Opinion | 64% Buy | 56% Buy | 100% Buy | 8% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.87% since 06/28/22 | -3.15% since 06/28/22 | +0.71% since 06/28/22 | +0.84% since 06/28/22 | +0.08% since 06/28/22 |
| Low | 1.0400 on 06/30/22 | 74.63 on 07/05/22 | 240.72 on 07/01/22 | 61.27 on 07/01/22 | 583.05 on 06/30/22 |
| High | 1.1000 on 07/06/22 | 79.17 on 06/29/22 | 248.08 on 07/06/22 | 62.97 on 06/29/22 | 607.41 on 06/29/22 |
| 1-Month | |||||
| %Chg | -6.84% since 06/06/22 | +1.29% since 06/06/22 | -0.08% since 06/06/22 | +1.13% since 06/06/22 | -2.32% since 06/06/22 |
| Low | 1.0400 on 06/30/22 | 71.71 on 06/16/22 | 229.49 on 06/17/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 1.1799 on 06/08/22 | 80.59 on 06/27/22 | 248.08 on 07/06/22 | 63.53 on 06/27/22 | 622.84 on 06/08/22 |
| 3-Month | |||||
| %Chg | -30.13% since 04/06/22 | +1.17% since 04/06/22 | -1.87% since 04/06/22 | +3.14% since 04/06/22 | -16.02% since 04/06/22 |
| Low | 0.9829 on 05/12/22 | 71.71 on 06/16/22 | 227.32 on 05/02/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 1.6000 on 04/07/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 65.46 on 05/26/22 | 747.42 on 04/08/22 |
| 6-Month | |||||
| %Chg | +25.06% since 01/06/22 | +23.98% since 01/06/22 | +8.92% since 01/06/22 | -12.38% since 01/06/22 | -0.59% since 01/06/22 |
| Low | 0.7000 on 02/24/22 | 61.19 on 01/24/22 | 214.39 on 02/24/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 2.0000 on 04/04/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 72.57 on 01/11/22 | 747.42 on 04/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 51,299 | 161,723,696 | 131,803,168 | 78,193,872 | 64,750,024 |
| Shares Outstanding, K | 47,063 | 2,129,064 | 534,200 | 1,254,313 | 108,539 |
| Annual Sales | 38,350,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -27,580,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 16,090,000 | 11,648,000,000 | 6,238,000,000 | 6,590,000,000 | 2,965,100,000 |
| Last Quarter Net Income | -2,290,000 | 1,278,000,000 | 1,476,000,000 | 19,000,000 | 973,500,000 |
| 60-Month Beta | 1.92 | 0.45 | 0.58 | 0.38 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 05/16/22 | 1.96 on 04/29/22 | 4.25 on 04/27/22 | 2.12 on 04/28/22 | 11.49 on 05/04/22 |
| Latest Earnings Date | 08/15/22 | 07/27/22 | 08/02/22 | 08/04/22 | 08/04/22 |
| Most Recent Dividend | N/A | 0.540 on 06/30/22 | 1.940 on 05/16/22 | 0.730 on 06/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 06/30/22 | 05/16/22 | 06/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.95 | 13.90 | 8.51 | 7.58 |
